Your browser doesn't support javascript.
loading
Incidence and Prevalence of Children's Diffuse Lung Disease in Spain.
Torrent-Vernetta, Alba; Gaboli, Mirella; Castillo-Corullón, Silvia; Mondéjar-López, Pedro; Sanz Santiago, Verónica; Costa-Colomer, Jordi; Osona, Borja; Torres-Borrego, Javier; de la Serna-Blázquez, Olga; Bellón Alonso, Sara; Caro Aguilera, Pilar; Gimeno-Díaz de Atauri, Álvaro; Valenzuela Soria, Alfredo; Ayats, Roser; Martin de Vicente, Carlos; Velasco González, Valle; Moure González, José Domingo; Canino Calderín, Elisa María; Pastor-Vivero, María Dolores; Villar Álvarez, María Ángeles; Rovira-Amigo, Sandra; Iglesias Serrano, Ignacio; Díez Izquierdo, Ana; de Mir Messa, Inés; Gartner, Silvia; Navarro, Alexandra; Baz-Redón, Noelia; Carmona, Rosario; Camats-Tarruella, Núria; Fernández-Cancio, Mónica; Rapp, Christina; Dopazo, Joaquin; Griese, Matthias; Moreno-Galdó, Antonio.
Afiliação
  • Torrent-Vernetta A; Paediatric Allergy and Pulmonology Section, Department of Paediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department o
  • Gaboli M; Paediatric Allergy and Pulmonology Section, Department of Paediatrics, University Hospital Virgen del Rocío, Sevilla, Spain.
  • Castillo-Corullón S; Paediatric Pulmonology and Cystic Fibrosis Department, Hospital Clínico Universitario de Valencia, Spain.
  • Mondéjar-López P; Paediatric Pulmonology and Cystic Fibrosis Unit, University Clinic Virgen de la Arrixaca Hospital, University of Murcia, Spain.
  • Sanz Santiago V; Paediatric Pulmonology and Cystic Fibrosis Department, Hospital Universitario Infantil Niño Jesús, Madrid, Spain.
  • Costa-Colomer J; Paediatric Pulmonology and Cystic Fibrosis Department, Hospital Sant Joan de Déu, Barcelona, Spain.
  • Osona B; Paediatric Pulmonology and Allergology Department, Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Torres-Borrego J; Hospital Universitario Reina Sofía, Córdoba, Spain.
  • de la Serna-Blázquez O; Paediatric Pulmonology Department, Hospital Universitario La Paz, Madrid, Spain.
  • Bellón Alonso S; Paediatric Pulmonology Department, Paediatrics Department, Hospital Universitario Gregorio Marañón, Madrid, Spain.
  • Caro Aguilera P; Paediatric Pulmonology Department, Hospital Regional Universitario de Málaga, IBIMA, Spain.
  • Gimeno-Díaz de Atauri Á; Paediatric Pulmonology and Allergology Department, 12 de Octubre University Hospital, Madrid, Spain.
  • Valenzuela Soria A; Paediatric Pulmonology Department, Hospital Universitario Virgen de las Nieves, Granada, Spain.
  • Ayats R; Paediatric Pulmonology and Allergology Department, Parc Taulí Hospital Universitari, Institut d'Investigació i Innovació Parc Taulí I3PT, Sabadell, Universitat Autònoma de Barcelona, Barcelona, Spain.
  • Martin de Vicente C; Paediatric Pulmonology Department, Hospital Universitario Miguel Servet, Zaragoza, Spain.
  • Velasco González V; Paediatric Pulmonology Department, Hospital Universitario de Canarias, Tenerife, Spain.
  • Moure González JD; Paediatric Pulmonology and Allergology Department, Paediatrics Department, Hospital Clínico Universitario de Santiago, Spain.
  • Canino Calderín EM; Paediatric Pulmonology Department, Hospital Universitario Materno Infantil Canarias, Las Palmas de Gran Canaria, Spain.
  • Pastor-Vivero MD; Paediatric Pulmonology Department, Hospital Universitario Cruces, IIS Biocruces Bizkaia, Barakaldo, Bizkaia, Spain.
  • Villar Álvarez MÁ; Paediatric Pulmonology Department, Hospital Universitario Basurto, Bilbao, Spain.
  • Rovira-Amigo S; Paediatric Allergy and Pulmonology Section, Department of Paediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department o
  • Iglesias Serrano I; Paediatric Allergy and Pulmonology Section, Department of Paediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department o
  • Díez Izquierdo A; Paediatric Allergy and Pulmonology Section, Department of Paediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department o
  • de Mir Messa I; Paediatric Allergy and Pulmonology Section, Department of Paediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department o
  • Gartner S; Paediatric Allergy and Pulmonology Section, Department of Paediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department o
  • Navarro A; Pathology Department, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Spain.
  • Baz-Redón N; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Paediatrics, Obstetrics, Gynecology, Preventative Medicine and Public Health, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain.
  • Carmona R; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, University Hospital Virgen del Rocío, Sevilla, Spain.
  • Camats-Tarruella N; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Paediatrics, Obstetrics, Gynecology, Preventative Medicine and Public Health, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain; Center for Biomedical Research on Rare Disease
  • Fernández-Cancio M; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department of Paediatrics, Obstetrics, Gynecology, Preventative Medicine and Public Health, Universitat Autònoma de Barcelona, Bellaterra, Barcelona, Spain; Center for Biomedical Research on Rare Disease
  • Rapp C; Division of Pediatric Pneumology, Dr. von Hauner Children's Hospital, University Hospital Munich, Germany.
  • Dopazo J; Clinical Bioinformatics Area, Fundación Progreso y Salud (FPS), CDCA, University Hospital Virgen del Rocío, Sevilla, Spain; Computational Systems Medicine, Institute of Biomedicine of Seville (IBIS), Bioinformatics in Rare Diseases (BiER), Centro de Investigación Biomédica en Red de Enfermedades Rar
  • Griese M; Division of Pediatric Pneumology, Dr. von Hauner Children's Hospital, University Hospital Munich, Germany.
  • Moreno-Galdó A; Paediatric Allergy and Pulmonology Section, Department of Paediatrics, Vall d'Hebron Hospital Universitari, Vall d'Hebron Barcelona Hospital Campus, Universitat Autònoma de Barcelona, Spain; Vall d'Hebron Institut de Recerca (VHIR), Hospital Universitari Vall d'Hebron, Barcelona, Spain; Department o
Arch Bronconeumol ; 58(1): 22-29, 2022 Jan.
Article em En, Es | MEDLINE | ID: mdl-35249699
ABSTRACT

BACKGROUND:

Children's diffuse lung disease, also known as children's Interstitial Lung Diseases (chILD), are a heterogeneous group of rare diseases with relevant morbidity and mortality, which diagnosis and classification are very complex. Epidemiological data are scarce. The aim of this study was to analyse incidence and prevalence of chILD in Spain.

METHODS:

Multicentre observational prospective study in patients from 0 to 18 years of age with chILD to analyse its incidence and prevalence in Spain, based on data reported in 2018 and 2019.

RESULTS:

A total of 381 cases with chILD were notified from 51 paediatric pulmonology units all over Spain, covering the 91.7% of the paediatric population. The average incidence of chILD was 8.18 (CI 95% 6.28-10.48) new cases/million of children per year. The average prevalence of chILD was 46.53 (CI 95% 41.81-51.62) cases/million of children. The age group with the highest prevalence were children under 1 year of age. Different types of disorders were seen in children 2-18 years of age compared with children 0-2 years of age. Most frequent cases were primary pulmonary interstitial glycogenosis in neonates (17/65), neuroendocrine cell hyperplasia of infancy in infants from 1 to 12 months (44/144), idiopathic pulmonary haemosiderosis in children from 1 to 5 years old (13/74), hypersensitivity pneumonitis in children from 5 to 10 years old (9/51), and scleroderma in older than 10 years old (8/47).

CONCLUSIONS:

We found a higher incidence and prevalence of chILD than previously described probably due to greater understanding and increased clinician awareness of these rare diseases.
Palavras-chave

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En / Es Revista: Arch Bronconeumol Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Bases de dados: MEDLINE Tipo de estudo: Incidence_studies / Observational_studies / Prevalence_studies / Risk_factors_studies Idioma: En / Es Revista: Arch Bronconeumol Ano de publicação: 2022 Tipo de documento: Article